NEW YORK, March 15 - Applied Biosystems and MDS on Friday said they have won a patent infringement suit filed against Micromass UK and will walk away with $47.5 million in damages.
The Federal District Court in Wilmington, in Delaware, has ruled that Micromass' Quattro Ultima systems, which includes the MassTRANSIT version, infringe ABI's and MDS' US Patent No. 4,963,736.
According to a joint statement released by ABI and MDS, which together have a partnership called Applied Biosystems/MDS Sciex Instruments, the patent covers technology for "triple quadrupole mass spectrometers."
The court is expected to meet next week to enter the final judgment in the case, which was filed on Feb. 18, 2000.
"Our scientific leadership in the area of triple quadrupole mass spectrometry is the result of significant investments in research and development made over the last decade," Andy Boorn, president of MDS Sciex, the Toronto-based analytic instrumentation division of MDS.
Officials from Micromass were not available for comment.